Ancora Advisors’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Ancora Advisors’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	3,000	–	–	﹤0.01%	2426
2026 Q1	$0	Hold	3,000	–	–	﹤0.01%	2586
2025 Q4	$0	Hold	3,000	–	–	﹤0.01%	2532
2025 Q3	$0	Hold	3,000	–	–	﹤0.01%	2093
2025 Q2	$0	Hold	3,000	–	–	﹤0.01%	2076
2025 Q1	$1	Hold	3,000	–	–	﹤0.01%	1766
2024 Q4	$0	Hold	3,000	–	–	﹤0.01%	1934
2024 Q3	$0	Hold	3,000	–	–	﹤0.01%	1950
2024 Q2	$37	Buy	+3,000	New	+$37	﹤0.01%	1811

Ancora Advisors's BTTX Position: Q2 2026 in Review

Ancora Advisors held its Better Therapeutics, Inc. Common Stock (BTTX) position steady in Q2 2026 at 3,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2426.

Ancora Advisors first reported a position in BTTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $37 in Q2 2024. 1 fund tracked by Wall St. Rank holds BTTX as of Q2 2026.

Ancora Advisors held 3,000 shares of Better Therapeutics, Inc. Common Stock worth $0 as of Q2 2026.
Ancora Advisors left its Better Therapeutics, Inc. Common Stock share count unchanged in Q2 2026.
Better Therapeutics, Inc. Common Stock made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #2426 holding.
Ancora Advisors first reported a position in Better Therapeutics, Inc. Common Stock in Q2 2024 and has held it in 9 quarters since.
Ancora Advisors's Better Therapeutics, Inc. Common Stock position peaked at $37 in Q2 2024.
1 fund tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.